Clinical Trial Update: EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated EPOCH chemotherapy with Rituximab for HIV-associated non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Lymphoma
• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituxan (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: COMPLETED | Results posted: 2022-06-28